T. Rowe Price Associates’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $129M | Sell |
|
|||||
|
2019
Q2 | $189M | Sell |
|
|||||
|
2019
Q1 | $379M | Sell |
|
|||||
|
2018
Q4 | $321M | Sell |
|
|||||
|
2018
Q3 | $887M | Buy |
|
|||||
|
2018
Q2 | $261M | Buy |
|
|||||
|
2018
Q1 | $287M | Sell |
|
|||||
|
2017
Q4 | $854M | Sell |
|
|||||
|
2017
Q3 | $1.64B | Sell |
|
|||||
|
2017
Q2 | $1.61B | Sell |
|
|||||
|
2017
Q1 | $1.84B | Sell |
|
|||||
|
2016
Q4 | $1.89B | Sell |
|
|||||
|
2016
Q3 | $1.88B | Sell |
|
|||||
|
2016
Q2 | $1.85B | Sell |
|
|||||
|
2016
Q1 | $2.18B | Sell |
|
|||||
|
2015
Q4 | $3.15B | Sell |
|
|||||
|
2015
Q3 | $3.05B | Buy |
|
|||||
|
2015
Q2 | $3.2B | Sell |
|
|||||
|
2015
Q1 | $3.2B | Buy |
|
|||||
|
2014
Q4 | $3.02B | Sell |
|
|||||
|
2014
Q3 | $2.58B | Buy |
|
|||||
|
2014
Q2 | $2.29B | Buy |
|
|||||
|
2014
Q1 | $1.84B | Sell |
|
|||||
|
2013
Q4 | $2.38B | Sell |
|
|||||
|
2013
Q3 | $2.21B | Buy |
|
|||||
|
2013
Q2 | $1.63B | Buy |
|